Stephen Oh, MD, PhD


Primary Academic Title

Assistant Professor of Medicine, Division of Hematology, Washington University School of Medicine

Clinical Expertise

Hematology, myeloproliferative neoplasms

Research Interest

Dysregulated signaling is a hallmark of myeloproliferative neoplasms (MPNs). By directly examining primary patient samples, patient-specific signaling profiles can be generated at the single-cell level utilizing phospo-specific flow cytometry. This approach facilitates the identification of pathways and targets amenable to therapeutic intervention. The ultimate goal is to develop more specific therapies for MPN Patients.


  • 2002: PhD, cancer biology, Northwestern University, Chicago
  • 2004: MD, Northwestern University


  • 2004 - 2006: Resident, internal medicine, Stanford University, Stanford, Calif.
  • 2006 - 2010: Fellow, hematology/oncology, Stanford University

Board Certification

  • 2007: American Board of Internal Medicine, Internal Medicine
  • 2010: American Board of Internal Medicine, Hematology

Journal Articles

Disclaimer: This listing may not include all articles associated with this physician and may include publications related to other physicians with a similar name.

View All Journal Articles

Contact Information

  • Washington University Medical Campus

    4921 Parkview Place
    Saint Louis, MO 63110

Phone Numbers
Request an appointment